Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGraphene Nanochem Regulatory News (GRPH)

  • There is currently no data for GRPH

Holding(s) in Company

30 Oct 2009 15:05

RNS Number : 7025B
Biofutures International plc
30 October 2009
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

BIOFUTURES INTERNATIONAL PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Full name of person(s) subject to the notification obligation:

 

BIOFUTURES INTERNATIONAL PLC

4. Full name of shareholder(s) (if different from 3.):

RELIGARE HICHENS, HARRISON PLC 

5. Date of the transaction and date on which the threshold is crossed or reached:

 

30 OCTOBER 2009

6. Date on which issuer notified:

 

30 OCTOBER 2009

7. Threshold(s) that is/are crossed or reached:

 8%

  

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

ORDINARY

GB00B12B4T47

 

 11,712,177

 11,712,177

 10,462,177

 10,462,177

 -

 6.92%

 -

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

OPTION TO SUBSCRIBE FOR NEW ORDINARY SHARES 

 4.875P

 31/08/2012

 29/08/2008 - 31/08/2012

 1,510,600

Nominal

Delta

1.00%

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

11,972,777

7.92%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

ORDINARY SHARES HELD BY RELIGARE HICHENS, HARRISON PLC

OPTION TO SUBSCRIBE FOR NEW ORDINARY SHARES HELD BY BLOMFIELD CORPORATE FINANCE LIMITED, A WHOLLY-OWNED SUBSIDIARY OF RELIGARE HICHENS, HARRISON PLC

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

 

14. Contact name:

 GARY PITTS

15. Contact telephone number:

 0207 444 0500

For further information contact:

JULIE POMEROY, FINANCE DIRECTOR, BIOFUTURES INTERNATIONAL PLC - 07936 848343

DEREK CROWHURST, BLOMFIELD CORPORATE FINANCE LIMITED - 0207 444 0800

DANIEL BRIGGS, RELIGARE HICHENS, HARRISON PLC - 0207 444 0500

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLMMBATMMMJBJL
Date   Source Headline
16th Mar 20187:00 amRNSAcquisition Update and AIM Cancellation
16th Feb 20187:00 amRNSConfirmation of Resignation of Nomad and Broker
31st Jan 20181:47 pmRNSNotice of Resignation of Nomad and Broker
17th Jan 20189:24 amRNSResignation of Director
8th Jan 20182:50 pmRNSProposed Acquisition Update
30th Nov 20177:30 amRNSSuspension - Graphene Nanochem Plc
30th Nov 20177:00 amRNSProposed Acquisition and Suspension of Trading
12th Oct 20174:40 pmRNSSecond Price Monitoring Extn
12th Oct 20174:35 pmRNSPrice Monitoring Extension
11th Oct 20174:40 pmRNSSecond Price Monitoring Extn
11th Oct 20174:35 pmRNSPrice Monitoring Extension
29th Sep 201711:30 amRNSInterim Results
13th Sep 20179:31 amRNSHolding(s) in Company
13th Sep 20179:27 amRNSHolding(s) in Company
11th Sep 201712:07 pmRNSSecond Price Monitoring Extn
11th Sep 201712:02 pmRNSPrice Monitoring Extension
11th Sep 201711:45 amRNSConversion of Loan Notes and Issue of Equity
4th Sep 201710:15 amRNSConversion of loan note and issue of equity
2nd Aug 20171:20 pmRNSConversion of loan note and issue of equity
26th Jul 201711:30 amRNSResult of Annual General Meeting
4th Jul 20179:59 amRNSConversion of loan note and issue of equity
30th Jun 20177:03 amRNSPreliminary Results
27th Jun 20174:35 pmRNSPrice Monitoring Extension
23rd Jun 20174:35 pmRNSPrice Monitoring Extension
13th Jun 20177:00 amRNSPolymer Division Paid Pilot
22nd May 201712:54 pmRNSPlatDrill Deployment In Myanmar
15th May 201712:35 pmRNSIssuance of Tranche 2 Loan Notes
12th Apr 20172:47 pmRNSConversion of loan note and issue of equity
3rd Apr 201711:47 amRNSConversion of Loan Note and Issue of Equity
31st Mar 20179:05 amRNSUpdate on Debt Rationalisation
8th Mar 201712:00 pmRNSConversion of loan note and issue of equity
3rd Mar 20177:00 amRNSCommercial deployment in Turkmenistan
20th Feb 20174:40 pmRNSSecond Price Monitoring Extn
20th Feb 20174:35 pmRNSPrice Monitoring Extension
3rd Feb 20177:00 amRNSConversion of loan note and issue of equity
29th Dec 20164:19 pmRNSFurther information on 2015 report and accounts
28th Dec 20167:00 amRNSContract Win
23rd Dec 201612:35 pmRNSPrice Monitoring Extension
23rd Dec 20168:45 amRNSRestoration - Graphene NanoChem PLC
23rd Dec 20168:15 amRNSIssuance of Loan Notes and Resumption of Trading
6th Dec 20162:44 pmRNSResult of AGM
14th Nov 20165:04 pmRNSInterim Results
14th Nov 20165:01 pmRNSProposed Share Capital Reorganisation
14th Nov 20165:00 pmRNSPreliminary Results
31st Oct 20164:35 pmRNSUpdate on pending 2015 Annual Results
30th Sep 20163:20 pmRNSUpdate on 2015 Annual Results & 2016 Interims
1st Sep 20161:21 pmRNSUpdate on pending 2015 Annual Results
29th Jul 20167:00 amRNSUpdate on pending 2015 Annual Results
29th Jun 20167:30 amRNSStatement re. Suspension
29th Jun 20167:30 amRNSSuspension - Graphene Nanochem Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.